🚀 A Decade +26% CAGR & 20% MDD Portfolio
Combine Ultra Defensive & Alpha Allocation Portfolio Result: A Decade +26% CAGR & -20% MDD
To read our full disclaimer, click here.
PS…Ready to go deeper?
Subscribe now and unlock secret to build portfolio boasting over a decade with +26% CAGR and just 20% MDD. Get our in-depth posts, the latest allocation updates, market insights, AND BONUS….
🔔 FREE Subscriber Bonus:
$0 to $100,000 Wealth Building Guide - Learn how to build your wealth fast in stock market
Alpha Allocation Portfolio - Trade Orders, Daily NAV & Full Reports (up to 2025)
🔔 Paid Subscriber Bonus:
Alpha Allocation Portfolio Investment Journal (2025) - Explain the rational of every investment decisions in 2025 to help you to learn from us
Super Easy Beating Market Portfolio - A monthly rotation portfolio to beat market easily
Ultra Defensive Growth Portfolio - Trade Orders, Daily NAV & Full Reports (up to 2025)
Disclaimer: This content is solely for informational and educational purposes. The content herein does not constitute, and shall not be construed as, financial, legal, or investment advice. It is not an offer, solicitation, or recommendation to engage in any transaction involving securities or other financial instruments.
All insights presented reflect the author’s independent observations and analysis as of the date of publication. This content is not tailored to the specific investment objectives, financial situation, or particular needs of any individual recipient. Accordingly, readers should not make any investment decision based solely on this content without seeking independent professional advice and performing their own due diligence.
Investing in financial markets involves significant risk, including the potential loss of all capital invested. Historical performance data and backtesting results are provided for illustrative purposes only and are not a reliable indicator of future returns. FirstGlow Capital and its affiliates disclaim any liability for losses arising from the use of or reliance on the information contained in this journal.
To read our full disclaimer, click here.